Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Overview of "The Study in Risk-Based Manufacturing Environmental Control for Non-Sterile Drug Products"
Osamu Shirokizawa1, Keisuke Inoue2, Tsutomu Kamikukita3
1Life Scientia Limited; shirokizawa@lifescientia.com.
Abstract:
To develop a guide of best practices for establishing appropriate controls on nonsterile manufacturing environments for pharmaceutical manufacturers, the Kansai Study Group of the Parenteral Drug Association Japan Chapter explored relevant issues in-depth and published the results of their study, "The Study in Risk-Based Manufacturing Environmental Control for Non-Sterile Drug Products" in the PDA Journal of GMP and Validation in Japan. This review summarizes the background of that study and the structure of the published article and, to help readers make the most of the contents, provides a table displaying the category, subject, problem statement, and points to consider of each topic discussed in the article, as well as examples of central topics (Appendices 1-3).
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Product Stability
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Control Governance: Regulatory Bodies and Their Impact

